FDA Counselor Taylor Is Acting Deputy As Hamburg Mulls Reorganization
This article was originally published in The Pink Sheet Daily
Executive Summary
John Taylor, an agency veteran who returned in 2009 after five years in industry, will take over as acting principal deputy commissioner for 60 days following Joshua Sharfstein's departure on Jan. 7.
You may also be interested in...
FDA’s Congressional Relations, Internal Structure May Change With Sharfstein’s Departure
The departure of Principal Deputy Commissioner Joshua Sharfstein provides FDA an opportunity to take stock of its relationship with the new Congress and to re-evaluate its own organizational structure.
FDA’s Congressional Relations, Internal Structure May Change With Sharfstein’s Departure
The departure of Principal Deputy Commissioner Joshua Sharfstein provides FDA an opportunity to take stock of its relationship with the new Congress and to re-evaluate its own organizational structure.
FDA's Sharfstein Departs After Brief But Busy Tenure
The agency's principal deputy commissioner will become secretary of the Maryland Department of Health and Mental Hygiene.